WAF1, a potential mediator of p53 tumor suppression
NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions in protecting the public health.
It was also injected, which may have shown stronger results, even for gastrointestinal issues
Healthcare professionals must therefore balance the substantial benefits of GLP-1 therapy against this potential, though uncommon, risk when prescribing these agents
For nausea management Electrolytes alone will not eliminate GLP-1-related nausea, but they can reduce its severity
Patient characteristics associated with treatment discontinuation were similar for GLP-1 receptor agonists and SGLT2 inhibitors, although the association between higher BMI and a lower likelihood of treatment discontinuation was stronger for GLP-1 receptor agonists